Vasogen Announces Effective Date for Reverse Stock Split

TORONTO, April 16 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGN - News; TSX:VAS - News), a biotechnology Company focused on the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease, today announced the implementation of a one-for-ten reverse split (consolidation) of the Company's common stock that was approved by Vasogen's shareholders at its annual shareholder meeting held on April 3, 2007.

Back to news